199 related articles for article (PubMed ID: 19280348)
1. The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.
Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
AAPS PharmSciTech; 2009; 10(1):243-51. PubMed ID: 19280348
[TBL] [Abstract][Full Text] [Related]
2. The abbreviated impactor measurement (AIM) concept: part II--Influence of evaporation of a volatile component-evaluation with a "droplet-producing" pressurized metered dose inhaler (pMDI)-based formulation containing ethanol as cosolvent.
Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
AAPS PharmSciTech; 2009; 10(1):252-7. PubMed ID: 19291411
[TBL] [Abstract][Full Text] [Related]
3. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 1.
Mitchell JP; Nagel MW; Doyle CC; Ali RS; Avvakoumova VI; Christopher JD; Quiroz J; Strickland H; Tougas T; Lyapustina S
AAPS PharmSciTech; 2010 Jun; 11(2):843-51. PubMed ID: 20480271
[TBL] [Abstract][Full Text] [Related]
4. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 2--investigation of bias in extra-fine mass fraction with AIM-HRT impactor.
Mitchell JP; Nagel MW; Doyle CC; Ali RS; Avvakoumova VI; Christopher JD; Quiroz J; Strickland H; Tougas T; Lyapustina S
AAPS PharmSciTech; 2010 Sep; 11(3):1115-8. PubMed ID: 20623212
[TBL] [Abstract][Full Text] [Related]
5. Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.
Mitchell J; Copley M; Sizer Y; Russell T; Solomon D
J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):188-97. PubMed ID: 22857270
[TBL] [Abstract][Full Text] [Related]
6. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
[TBL] [Abstract][Full Text] [Related]
7. Addressing the Need for Controls on Particle Bounce and Re-entrainment in the Cascade Impactor and for the Mitigation of Electrostatic Charge for Aerodynamic Particle Size Assessment of Orally Inhaled Products: an Assessment by the International Consortium on Regulation and Science (IPAC-RS).
Doub W; Stein S; Mitchell J; Goodey AP
AAPS PharmSciTech; 2020 Aug; 21(7):239. PubMed ID: 32827121
[TBL] [Abstract][Full Text] [Related]
8. A Multi-laboratory in Vitro Study to Compare Data from Abbreviated and Pharmacopeial Impactor Measurements for Orally Inhaled Products: a Report of the European Aerosol Group (EPAG).
Nichols SC; Mitchell JP; Sandell D; Andersson PU; Fischer M; Howald M; Pengilley R; Krüger P
AAPS PharmSciTech; 2016 Dec; 17(6):1383-1392. PubMed ID: 26762338
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).
Mohan M; Lee S; Guo C; Peri SP; Doub WH
AAPS PharmSciTech; 2017 Jul; 18(5):1585-1594. PubMed ID: 27624069
[TBL] [Abstract][Full Text] [Related]
10. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI).
Guo C; Ngo D; Ahadi S; Doub WH
AAPS PharmSciTech; 2013 Sep; 14(3):1004-11. PubMed ID: 23780781
[TBL] [Abstract][Full Text] [Related]
12. Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs.
Mitchell JP; Stein SW; Doub W; Goodey AP; Christopher JD; Patel RB; Tougas TP; Lyapustina S
AAPS PharmSciTech; 2019 May; 20(5):206. PubMed ID: 31147791
[TBL] [Abstract][Full Text] [Related]
13. Introduction of the electrical next generation impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers.
Hoe S; Young PM; Chan HK; Traini D
Pharm Res; 2009 Feb; 26(2):431-7. PubMed ID: 19015961
[TBL] [Abstract][Full Text] [Related]
14. Effect of sampling volume on dry powder inhaler (DPI)-emitted aerosol aerodynamic particle size distributions (APSDs) measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen eight-stage cascade impactor (ACI).
Mohammed H; Roberts DL; Copley M; Hammond M; Nichols SC; Mitchell JP
AAPS PharmSciTech; 2012 Sep; 13(3):875-82. PubMed ID: 22678745
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Evaluation of Aerosol Performance and Delivery Efficiency During Mechanical Ventilation Between Soft Mist Inhaler and Pressurized Metered-Dose Inhaler.
Ke WR; Wang WJ; Lin TH; Wu CL; Huang SH; Wu HD; Chen CC
Respir Care; 2020 Jul; 65(7):1001-1010. PubMed ID: 32071134
[TBL] [Abstract][Full Text] [Related]
16. Particle Size Measurements from Orally Inhaled and Nasal Drug Products.
Mitchell JP
J Aerosol Med Pulm Drug Deliv; 2021 Dec; 34(6):325-345. PubMed ID: 34860563
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates.
Yoshida H; Kuwana A; Shibata H; Izutsu KI; Goda Y
AAPS PharmSciTech; 2017 Apr; 18(3):646-653. PubMed ID: 27173989
[TBL] [Abstract][Full Text] [Related]
18. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
Roberts DL; Mitchell JP
AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
[TBL] [Abstract][Full Text] [Related]
19. Is "Slow Inhalation" Always Suitable for Pressurized Metered Dose Inhaler?
Hira D; Okuda T; Mizutani A; Tomida N; Mizuno M; Ueshima S; Kakumoto M; Okano T; Okamoto H
AAPS PharmSciTech; 2020 Jan; 21(2):53. PubMed ID: 31907655
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Electrostatic Controls on MDI Size Distribution Measurements.
Stein SW; Rasmussen J; Walls S; Schultz DW; Oakley C; Drake JB
AAPS PharmSciTech; 2019 Apr; 20(5):170. PubMed ID: 31004248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
